Working with clinicians and scientists, WEHI researchers have developed infrastructure to access cancer samples directly from various partner hospitals, which are then rapidly processed in the laboratory to test their response to therapy.
It’s an approach that requires specialised equipment for the storage and analysis of human biological samples. Thanks to the Trust’s support, the Personalised Oncology Division was able to acquire a specialised biospecimen platform, including a biosafety cabinet, two specialised incubators, a water-bath and a centrifuge. These resources have significantly expedited the pace of research, enabling the team to prepare and analyse more samples and delve deeper into the unique genetic make-up of each patient’s cancer.
Most importantly, this has enabled researchers to identify potential new therapies that will enable more personalised treatment strategies, moving scientists one step closer to improving survival rates for patients diagnosed with these devastating cancers.